Clinical Trial Update: The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

View source ↗

Summary

This clinical trial update reports that the RECOVER sub-study, which used quantitative and credible research tools from Verily to assess depressive episodes in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Snippet

Sponsor: LivaNova | Conditions: Treatment Resistant Depression | Status: TERMINATED